Anticholinergic Toxicity in the Emergency Department
1University of California, Irvine, Department of Emergency Medicine, Orange, CA.
Journal of Education & Teaching in Emergency Medicine
|July 19, 2023
Summary
This simulation trains medical professionals to recognize and manage anticholinergic toxicity, a common emergency department presentation. Early identification and appropriate management are crucial for patient outcomes in anticholinergic poisoning.
Area of Science:
- Medical Education
- Toxicology
- Emergency Medicine
Background:
- Over 600 compounds possess anticholinergic properties, found in common medications and illicit substances.
- Anticholinergic toxicity presents with diverse symptoms, including agitation, seizures, hyperthermia, and cardiac dysrhythmias, posing a significant challenge in emergency settings.
- Familiarity with managing anticholinergic toxidrome is essential for emergency physicians due to frequent encounters.
Purpose of the Study:
- To develop and evaluate a simulation case for training healthcare professionals in managing anticholinergic toxicity.
- To enable learners to describe clinical presentations, identify causative agents, recognize ECG findings, and review management strategies for anticholinergic toxicity.
Main Methods:
- A high- or moderate-fidelity manikin simulation was employed for the educational scenario.
- The simulation was piloted with emergency medicine residents and subsequently tested on over 100 learners.
- Learner feedback was collected via oral feedback and debriefing sessions utilizing techniques like advocacy/inquiry.
Main Results:
- The simulation case was well-received by learners, who found it useful and engaging.
- Learners reported positive overall feedback, indicating the case's effectiveness in their training.
- The simulation proved effective when combined with structured debriefing sessions.
Conclusions:
- This simulation effectively enhances the ability of medical professionals to evaluate and manage anticholinergic toxicity.
- The training approach, incorporating manikin simulation and debriefing, is a valuable tool for improving preparedness in toxicology emergencies.
- Continued use and refinement of such simulation-based education can improve patient care for anticholinergic poisoning.
More Related Videos
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
921
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
921
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
716
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
716
Cholinergic Antagonists: Therapeutic Uses
777
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
777
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.3K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.3K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.0K
Cholinergic Antagonists: Pharmacological Actions
1.2K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.2K


